Cargando…
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
Sorafenib is a multi-targeted tyrosine kinase receptor inhibitor used to treat patients with advanced gastrointestinal stromal tumors (GISTs). The present study evaluated the efficacy and tolerability of sorafenib therapy for patients with GISTs. Between January 2001 and November 2012, 25 patients,...
Autores principales: | KEFELI, UMUT, BENEKLI, MUSTAFA, SEVINC, ALPER, YILDIZ, RAMAZAN, KAPLAN, MUHAMMED ALI, CILTAS, AYDIN, BALAKAN, OZAN, ISIKDOGAN, ABDURRAHMAN, COSKUN, UGUR, DANE, FAYSAL, HARPUTLUOGLU, HAKAN, KARACA, HALIT, YAZILITAS, DOGAN, DURNALI, AYSE, KAYA, ALI OSMAN, DEMIRCI, UMUT, GUMUS, MAHMUT, BUYUKBERBER, SULEYMAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789037/ https://www.ncbi.nlm.nih.gov/pubmed/24137379 http://dx.doi.org/10.3892/ol.2013.1408 |
Ejemplares similares
-
Four different malignancies in one patient: a case report
por: Demirci, Umut, et al.
Publicado: (2010) -
Synchronous testicular liposarcoma and prostate adenocarcinoma: a case report
por: Demirci, Umut, et al.
Publicado: (2010) -
Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology
por: Mehmet, Kucukoner, et al.
Publicado: (2014) -
Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia
por: Sevinç, Alper, et al.
Publicado: (2018) -
Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer
por: Akmansu, Muge, et al.
Publicado: (2010)